HTBX News and Press, Heat Biologics Inc. From 05/10/21

Heat Biologics ([[HTBX]] -1.8%) announces the appointment of Anthony Manning as the company's chief scientific advisor.Manning will be responsible for strategic initiatives to accelerate the development of Heat Biologics’ product portfolio.He brings over three decades of...

DURHAM, N.C., May 10, 2021 (GLOBE NEWSWIRE) --  Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, tod...

Heat Biologics (HTBX): Q1 GAAP EPS of -$0.31 misses by $0.01.Revenue of $0.54M (-40.0% Y/Y) misses by $0.08M.As of March 31, 2021, the Company had approximately $132 million in cash, cash equivalents and short investments.Shares +3.86% PM.Press Release For further details see: Heat Biol...

DURHAM, N.C., May 05, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX) , a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates...

#technicalanalysis provides insights that #fundamentalanalysis cannot.  We can use that to our #advantage in Heat Biologics Inc (NASDAQ: HTBX).   Using the data offered below we have a real-time example.  Review The technical data for HTBX below, and the adde...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you stumbled upon this morning’s more-than-1,000% jump in the price of InspireMD (NYSEMKT: NSPR ) stock on top of an even-bigger gain on Monday, allow us to unpack things for you. Today’s the day that...

How do we know what is going on behind the scenes of a company?  According to Stock Traders Daily, a 20-year industry innovator, the best way to do this to to watch the price action in the stock. The Heat Biologics Inc (NASDAQ: HTBX) report below is a real world example. Included a...

DURHAM, NC / ACCESSWIRE / April 12, 2021 / Heat Biologics, Inc. (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today reported ...

Best Biotech Stocks To Buy [Or Sell] In The Stock Market Today Biotech stocks are on many investors’ radar these days and for good reason. Given how these stocks are usually more sheltered from global events like economic uncertainty and a pandemic, it starts to be clear ...

Gainers: Ovid Therapeutics (OVID) +48%, KemPharm (KMPH) +46%, Ocugen (OCGN) +34%, Asensus Surgical (TRXC) +32%, Heat Biologics (HTBX) +16%.Losers: Vir Biotechnology (VIR) -29%, NanoViricides (NNVC) -16%, ASLAN Pharmaceutica...